Cargando…
Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD
Duchenne muscular dystrophy (DMD) is a lethal, X-linked muscle-wasting disease caused by lack of the cytoskeletal protein dystrophin. Constitutive utrophin expression, a structural and functional paralogue of dystrophin, can successfully prevent the dystrophic pathology in the dystrophin-deficient m...
Autores principales: | Guiraud, Simon, Edwards, Benjamin, Squire, Sarah E, Moir, Lee, Berg, Adam, Babbs, Arran, Ramadan, Nesrine, Wood, Matthew J, Davies, Kay E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322073/ https://www.ncbi.nlm.nih.gov/pubmed/30304405 http://dx.doi.org/10.1093/hmg/ddy353 |
Ejemplares similares
-
Identification of serum protein biomarkers for utrophin based DMD therapy
por: Guiraud, Simon, et al.
Publicado: (2017) -
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019) -
Second-generation compound for the modulation of utrophin in the therapy of DMD
por: Guiraud, Simon, et al.
Publicado: (2015) -
Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice
por: Kennedy, Tahnee L., et al.
Publicado: (2018) -
Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
por: Kennedy, Tahnee L., et al.
Publicado: (2017)